May 19,2015

Tandem Diabetes Care Launches t:flex™ Insulin Pump

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today announced that it is now taking orders for the t:flex™ Insulin Pump, with shipments planned to begin in June. The 480-unit t:flex Pump, cleared by the U.S. Food and Drug Administration in January 2015, is the largest capacity insulin pump currently offered in the United States.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
May 26,2015

LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel

LabStyle Innovations Corp. (DRIO), developer of the Dario™ Diabetes Management Solution, announced today that in partnership with Israel's leading HMO, Maccabi Healthcare, it has launched the comprehensive Dario™ Diabetes Management Solution as part of Maccabi's advanced Telecare unit (MOMA). The Dario™ is a proprietary customized diabetes management solution that enables remote treatment for diabetes aiming to improve overall outcomes for patients. Maccabi has integrated the Dario™ into MOMA, leveraging LabStyle's cutting edge online and mobile healthcare technologies.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Jun 03,2015

Glooko adds Dexcom CGM and Insulet OmniPod

Diabetes management software company Glooko will add its first two continuous glucose monitor and pump integrations into its offering: Dexcom's G4 CGM and Insulet's OmniPod Insulin Management System.

COLLABORATION PARTNERSHIP

#connected device

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 04,2015

Maker of diabetes management app One Drop raises $8 million

New York City and Austin, Texas-based Informed Data Systems has raised $8 million for its One Drop mobile diabetes management platform. The round was led by RRE, with additional contributions from BoxGroup, Capital Factory, and existing investors LAUNCH fund and Neu Ventures.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 05,2015

Medtronic gets major FDA nod

Medtronic has received FDA 510(k) clearance for its MiniMed Connect device, which allows users of Medtronic's continuous glucose monitor (CGM) and insulin pump to view data from those devices on their smartphone. At the same time, Medtronic announced a partnership with Samsung to optimize the viewing of this CGM and pump data.

REGULATORY FDA

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Jun 08,2015

Medtronic Partners with Samsung

The deal between Samsung Electronics and Medtronic, announced at the American Diabetes Association's 75th annual Scientific Sessions in Boston, seeks to bolster the capabilities of an Android-based mobile health management platform for diabetics and their caregivers.

COLLABORATION PARTNERSHIP

#product & service

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 10,2015

Survey: 65 percent want doctors to add tech tools to care plans

Some 58 percent of people with diabetes want to use technology to track their diets, according to an online survey of 2,535 American adults, conducted by Telcare through SurveyMonkey. Of those surveyed, 16 percent had diabetes, 61 percent knew someone living with diabetes, and 21 percent cared for someone with diabetes.

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Jun 10,2015

Panasonic scoops up Bayer's diabetes care business

Japan's Panasonic Healthcare Holdings has announced plans to acquire the diabetes care business of Bayer AG for roughly $1.13 billion. Bayer had tried to sell its Diabetes Care business unit – which includes the Contour portfolio of monitors and strips and Breeze2, Brio, Entrust, Elite and Microlet lancing devices – as early as 2012, before pulling back. Diabetes Care has a collaboration agreement in place with Medtronic, one of the biggest players in the mobile diabetes care management industry.

View Analyst & Ambassador Comments
Go to original news
Jun 18,2015

Small 2012 study found PHR app did not improve health-related quality of life

Patients with diabetes may be more likely benefit from a mobile phone-based health coaching program with remote monitoring than patients with heart disease, according to a study of 267 heart patients and 250 diabetes patients, which was conducted in 2012 by researchers in Finland and published in the Journal of Medical Internet Research.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 06,2015

New Clinical Data Suggest Infusion Set with BD FlowSmart Technology May Improve Insulin Flow and Reduce Silent Occlusions

BD Medical, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), released research on infusion sets that represents a potential improvement in insulin pump therapy for people with diabetes. Three different posters will be presented at the American Diabetes Association's annual meeting with data on a new insulin infusion set with BD FlowSmart(TM) technology. Infusion sets have been described as "the Achilles heel" of insulin pump therapy.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES